tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thomas Stephan, 50 are a HOLD (43.48%), 64 are a BUY (55.65%), 1 are a SELL (0.87%).
Analyst Thomas Stephan, currently employed at STIFEL, carries an average stock price target met ratio of 66.72% that have a potential upside of 15.77% achieved within 76 days.
Thomas Stephan’s has documented 233 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on STAA, STAAR Surgical Company at 29-Sep-2026.
Analyst best performing recommendations are on CLPT (CLEARPOINT NEURO).
The best stock recommendation documented was for RXST (RXSIGHT) at 8/10/2026. The price target of $7 was fulfilled within 1 day with a profit of $0.43 (6.54%) receiving and performance score of 65.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Apr-2022
$205
$40.16 (24.36%)
$202
9 days ago
(12-Oct-2026)
23/26 (88.46%)
$39.31 (23.73%)
80
Buy Since 22-Sep-2026
$210
$45.16 (27.40%)
$125
29 days ago
(22-Sep-2026)
1/2 (50%)
$50.14 (31.36%)
71
Buy Since 01-Aug-2024
$215
$50.16 (30.43%)
$180
2 months 21 days ago
(30-Jul-2026)
10/11 (90.91%)
$46.48 (27.58%)
298
Buy Since 04-Oct-2022
$201
$36.16 (21.94%)
$150
2 months 21 days ago
(30-Jul-2026)
20/21 (95.24%)
$32.48 (19.27%)
114
Buy Since 29-Sep-2025
$195
$30.16 (18.30%)
$165
2 months 21 days ago
(30-Jul-2026)
2/3 (66.67%)
$26.48 (15.71%)
167
Which stock is Thomas Stephan most bullish on?
Which stock is Thomas Stephan most reserved on?
What Year was the first public recommendation made by Thomas Stephan?
